MaRS Centre, 661 University Avenue, Suite 480
Toronto, Ontario, Canada, M5G 1M1
Pipeline
Our AI workbench is enabling the discovery of novel therapeutic targets for diseases with high unmet need.
THERAPEUTIC AREA | TARGET VALIDATION | DISCOVERY | PRECLINICAL | CLINICAL | PARTNER |
---|---|---|---|---|---|
CNS | |||||
Frontotemporal Dementia |
|
||||
Niemann-Pick Disease Type C |
|
||||
Pediatric Epilepsy |
|
||||
Parkinson's Disease |
|
||||
Metabolic | |||||
Wilson Disease |
|
||||
Refractory Gout |
|
||||
Partnered | |||||
Undisclosed |
|
![]() |
|||
Undisclosed |
|
![]() |
|||
Undisclosed |
|
![]() |
|||
Undisclosed |
|
![]() |
|||
Target Identification | |||||
Under Assessment (N=20) |
|